Sponsor Pipeline

Sinovac Life Sciences Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
7
Active Trials
4
Recruiting
3
Phase 3
Active Trials by Phase
Phase 3
3
Phase 2
2
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06617715 Clinical Trial of 13-Valent Pneumococcal Conjugate Vaccine Pneumococcal Infectious Disease Recruiting
NCT07593924 Clinical Trial of PCV13 in Infants Aged Approximately 2 Months (42 to 89 Days) Pneumococcal Infectious Diseases Not Yet Recruiting
NCT07633119 A Phase Ⅲ Clinical Study of SNA02-48 Injection Tetanus Not Yet Recruiting
Phase 2
NCT06967272 PhaseⅡClinical Trial of Oral Hexavalent Reassortant Rotavirus Attenuated Live Vaccine… Rotavirus Gastroenteritis Recruiting
NCT07300644 Clinical Trial of PCV24 in Infants and Children Aged 2 Months to 5 Years Pneumococcal Infectious Disease Recruiting
Phase 1
NCT06800261 Clinical Trial of PCV24 in Infants Aged 2-23 Months Pneumococcal Infectious Disease Recruiting
NCT07374510 Phase Ia Clinical Trial of Group ACYW135X Meningococcal Conjugate Vaccine Meningococcal Meningitis Not Yet Recruiting
Get alerts when Sinovac Life Sciences Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free